Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance Evaluation of Dream OCT: AP Study

NCT07355491 is registered in ClinicalTrials.gov with Intalight, Inc as lead sponsor.

NCT NCT07355491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07355491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance Evaluation of Dream OCT: AP Study
Lead sponsor
Intalight, Inc
Phase
Observational
Overall status
Completed
Start date
December 16, 2025
Completion date
May 12, 2026
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eyes with corneal abnormality, glaucoma patients, normal healthy eyes, retina patients